Cara Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2013 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Cara Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2013 to Q3 2024.
  • Cara Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 54.8M shares, a 0.69% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 54.8M +375K +0.69% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 54.8M +769K +1.42% Jun 30, 2024 10-Q 2024-08-14
Q1 2024 54.7M +693K +1.28% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 54.5M +683K +1.27% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 54.5M +738K +1.37% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 54.1M +359K +0.67% Jun 30, 2023 10-Q 2023-08-07
Q1 2023 54M +383K +0.72% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 53.8M +317K +0.59% Dec 31, 2022 10-K 2024-03-06
Q3 2022 53.7M +3.56M +7.09% Sep 30, 2022 10-Q 2022-11-07
Q2 2022 53.7M +3.62M +7.23% Jun 30, 2022 10-Q 2022-08-08
Q1 2022 53.6M +3.56M +7.13% Mar 31, 2022 10-Q 2022-05-09
Q4 2021 53.5M +3.61M +7.24% Dec 31, 2021 10-K 2023-03-06
Q3 2021 50.2M +3.28M +7% Sep 30, 2021 10-Q 2021-11-08
Q2 2021 50.1M +3.22M +6.88% Jun 30, 2021 10-Q 2021-08-09
Q1 2021 50M +3.3M +7.06% Mar 31, 2021 10-Q 2021-05-10
Q4 2020 49.9M +3.15M +6.75% Dec 31, 2020 10-K 2022-03-01
Q3 2020 46.9M +219K +0.47% Sep 30, 2020 10-Q 2020-11-09
Q2 2020 46.9M +6.84M +17.1% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 46.7M +7.15M +18.1% Mar 31, 2020 10-Q 2020-05-11
Q4 2019 46.7M +7.17M +18.1% Dec 31, 2019 10-K 2021-02-25
Q3 2019 46.7M +7.28M +18.5% Sep 30, 2019 10-Q 2019-11-05
Q2 2019 40M +5.97M +17.5% Jun 30, 2019 10-Q 2019-08-07
Q1 2019 39.6M +6.88M +21% Mar 31, 2019 10-Q 2019-05-07
Q4 2018 39.5M +6.89M +21.1% Dec 31, 2018 10-K 2020-02-27
Q3 2018 39.4M +6.78M +20.8% Sep 30, 2018 10-Q 2018-11-06
Q2 2018 34.1M +1.49M +4.58% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 32.7M +5.38M +19.7% Mar 31, 2018 10-Q 2018-05-09
Q4 2017 32.7M +5.37M +19.7% Dec 31, 2017 10-K 2019-03-12
Q3 2017 32.6M +5.33M +19.5% Sep 30, 2017 10-Q 2017-11-02
Q2 2017 32.6M +5.28M +19.4% Jun 30, 2017 10-Q 2017-08-03
Q1 2017 27.3M +41.3K +0.15% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 27.3M +42K +0.15% Dec 31, 2016 10-K 2018-03-15
Q3 2016 27.3M +51.3K +0.19% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 27.3M +4.45M +19.5% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 27.3M +4.46M +19.5% Mar 31, 2016 10-Q 2016-05-05
Q4 2015 27.3M +4.45M +19.5% Dec 31, 2015 10-K 2017-03-10
Q3 2015 27.2M +4.45M +19.5% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 22.8M +199K +0.88% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 22.8M +233K +1.03% Mar 31, 2015 10-Q 2015-05-12
Q4 2014 22.8M +18.5M +432% Dec 31, 2014 10-K 2016-03-11
Q3 2014 22.8M Sep 30, 2014 10-Q 2014-11-10
Q2 2014 22.6M Jun 30, 2014 10-Q 2014-08-07
Q1 2014 22.6M Mar 31, 2014 10-Q 2014-05-12
Q4 2013 4.29M Dec 31, 2013 10-K 2015-03-27
* An asterisk sign (*) next to the value indicates that the value is likely invalid.